
<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>Types of Award Mechanisms – NIH Grant Writing Guide  </title>
<style>

<style>
/* ===== GENERAL LAYOUT ===== */
body {
    font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
    background: linear-gradient(135deg, #eef2ff, #fafafa);
    color: #2c2c2c;
    padding: 30px;
    margin: 0;
}

/* Centered mindmap container */
.mindmap {
    max-width: 800px;
    margin: auto;
    font-size: 20px;
    line-height: 1.7;
}

/* ===== LISTS ===== */
.mindmap ul {
    margin: 0.6em 0 1em 1.5em;
    padding-left: 1.4em;
    list-style: disc;
    color: #555;
    font-size: 0.95em;
    font-weight: 400;
    line-height: 1.6;
}

.mindmap li::marker {
    color: #8b5cf6; /* accent bullet color */
}

.mindmap li {
    margin-bottom: 6px;
    padding-left: 4px;
}

/* ===== COLLAPSIBLE SECTIONS ===== */
.mindmap details {
    /* FIX: Increased border width and used a darker color */
    border-left: 5px solid #7c3aed; 
    background: #ffffff;
    margin: 8px 0;
    /* FIX: Corrected typo "20x" to "20px" */
    padding: 9px 25px; 
    border-radius: 20px;
    box-shadow: 0 4px 12px rgba(139, 92, 246, 0.1);
    transition: all 0.3s ease;
    position: relative;
}

/* Subsection (nested details) */
.mindmap details > div > details {
    margin-left: -8px;
    /* FIX: Used a darker, more saturated color for the nested border */
    border-color: #9333ea; 
    background: #faf7ff;
}

/* Subtle hover feedback */
.mindmap details:hover {
    box-shadow: 0 6px 18px rgba(139, 92, 246, 0.18);
    background: linear-gradient(135deg, #ffffff, #f5f0ff);
}

/* ===== SUMMARY HEADERS ===== */
.mindmap summary {
    cursor: pointer;
    font-size: 1.1em;
    font-weight: 600;
    list-style: none;
    position: relative;
    /* FIX: Increased padding slightly to prevent text from touching the arrow icon */
    padding-left: 24px; 
    color: #4c1d95;
    outline: none;
}

/* Custom arrow icon */
.mindmap summary::before {
    content: "▶";
    position: absolute;
    left: 0;
    top: 2px;
    transition: transform 0.3s ease;
    font-size: 1em;
    color: #7c3aed;
}

/* Rotated arrow when open */
.mindmap details[open] > summary::before {
    transform: rotate(90deg);
}

/* Section title emphasis */
.mindmap summary strong {
    display: block;
    font-size: 1.25em;
    color: #4c1d95;
}

.mindmap summary em {
    font-style: normal;
    color: #6b21a8;
    font-size: 0.95em;
}

/* Open section highlighting */
.mindmap details[open] > summary {
    background: #f3e8ff;
    border-radius: 8px;
    padding: 6px 10px;
}

/* Smooth fade for expanded content */
.mindmap details[open] > div {
    animation: fadeIn 0.3s ease-in;
}

/* ===== DESCRIPTION BOXES ===== */
.mindmap .desc-box {
    background: #fdfcff;
    border: 2px solid #e5d9fb;
    border-left: 4px solid #c084fc;
    padding: 6px 10px;
    margin: 12px 0 18px 0;
    border-radius: 12px;
    box-shadow: 0 1px 3px rgba(160, 104, 255, 0.05);
    transition: background 0.3s ease;
}
.mindmap .desc-box:hover {
    background: #f8f4ff;
}

/* ===== ANIMATIONS ===== */
@keyframes fadeIn {
    from { opacity: 0; transform: translateY(-3px); }
    to { opacity: 1; transform: translateY(0); }
}

/* ===== BUTTONS ===== */
button {
    background-color: #7c3aed;
    color: white;
    border: none;
    padding: 10px 16px;
    margin: 0 6px;
    font-size: 2em;
    border-radius: 8px;
    cursor: pointer;
    transition: background 0.3s ease, transform 0.2s ease;
}
button:hover {
    background-color: #6b21a8;
    transform: scale(1.05);
}

/* ===== FLOATING CONTROL PANEL ===== */
#level-controls {
    position: fixed;
    bottom: 30px;
    left: 85%;
    transform: translateX(-50%);
    background: rgba(255, 255, 255, 0.05);
    padding: 10px 16px;
    border-radius: 12px;
    box-shadow: 0 4px 12px rgba(0, 0, 0, 0.15);
    z-index: 9999;
    backdrop-filter: blur(6px);
    cursor: move;
    display: flex;
    align-items: center;
    gap: 6px;
}

/* Buttons inside the panel */
#level-controls button {
    background-color: rgba(124, 58, 237, 0.85);
    color: white;
    border: none;
    padding: 8px 14px;
    font-size: 2em;
    border-radius: 8px;
    cursor: pointer;
    transition: background 0.3s ease, transform 0.2s ease;
}
#level-controls button:hover {
    background-color: rgba(107, 33, 168, 0.95);
    transform: scale(1.05);
}

/* Search input inside panel */
#level-controls input {
    border: 1px solid #d5c4ff;
    border-radius: 8px;
    padding: 7px 10px;
    font-size: 0.95em;
    outline: none;
    width: 150px;
    transition: border-color 0.2s ease;
}
#level-controls input:focus {
    border-color: #8b5cf6;
}

/* Search count text */
#searchCount {
    margin-left: 8px;
    font-style: italic;
    color: #4c1d95;
    font-size: 0.9em;
}

/* ===== SEARCH HIGHLIGHT ===== */
mark.search-highlight {
    background-color: #fff59d;
    color: #000;
    border-radius: 3px;
    padding: 1px 3px;
}



/* ===== CLICK-TO-REVEAL: Spoiler Blur Style ===== */
.mindmap q {
    cursor: pointer;
    color: transparent;
    /* Apply a text-shadow with the same color as the text to create the blur effect */
    text-shadow: 0 0 8px #2c2c2c; 
    user-select: none;
    transition: text-shadow 0.3s ease;
}

.mindmap q:hover {
    text-shadow: 0 0 4px #2c2c2c; /* Reduce blur on hover */
}

/* Style for the revealed text */
.mindmap q.is-revealed {
    color: inherit;
    text-shadow: none;
    cursor: default;
    user-select: text;
}




/*for full control button*/
/* ===== CLICK-TO-REVEAL: Spoiler Blur Style (with Read Mode) ===== */

/* This rule applies the blur ONLY when the mindmap is NOT in read-mode. */
.mindmap:not(.read-mode) q {
    cursor: pointer;
    color: transparent;
    text-shadow: 0 0 8px #2c2c2c; 
    user-select: none;
    transition: text-shadow 0.3s ease, color 0.3s ease;
}

.mindmap:not(.read-mode) q:hover {
    text-shadow: 0 0 4px #2c2c2c; /* Reduce blur on hover */
}

/* This combined rule handles BOTH cases for revealing text:
   1. The entire mindmap is in read-mode.
   2. An individual <q> has been clicked (in quiz mode).
*/
.mindmap.read-mode q,
.mindmap q.is-revealed {
    color: inherit;
    text-shadow: none;
    cursor: default;
    user-select: text;
}


</style>

</style>
</head>
<body>

<!-- Updated Controls -->
<div id="level-controls" onmousedown="dragElement(this)">
    <button onclick="zoomIn()">+</button>
    <button onclick="zoomOut()">-</button>
    <button onclick="resetView()">=</button>
    <!-- NEW: READ MODE TOGGLE BUTTON -->
    <button onclick="toggleReadMode()">Q/R</button>
</div>

<div class="mindmap">
<div class="mindmap">
<details><summary><strong>Types of Award Mechanisms – NIH Grant Writing Guide  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Source: <em>Writing the NIH Grant Proposal: A Step‑by‑Step Guide</em> (2026)  </li>
</ul>
<details><summary><strong>1. Foundations of a Strong Application  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;"><strong>Idea quality</strong>: must address an important public‑health problem.  </li>
<li style="margin-left: 0px;"><strong>Innovation</strong>: novel hypothesis, methods, or statistical approaches; avoid “too risky”.  </li>
<li style="margin-left: 0px;"><strong>Field impact</strong>: demonstrate how results will move the field forward (e.g., larger sample, gold‑standard measures).  </li>
<li style="margin-left: 0px;"><strong>Passion &amp; clarity</strong>: convey excitement; logical exposition hooks reviewers.  </li>
</ul>
<details><summary><strong>1.1 Characteristics of a Good Idea  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Begins with <strong>significant public‑health issue</strong>.  </li>
<li style="margin-left: 0px;">Shows <strong>innovation</strong> without exceeding feasible risk.  </li>
<li style="margin-left: 0px;">Provides <strong>clear advancement</strong> over prior work (sample size, confound control).  </li>
</ul>
</div></details>
<details><summary><strong>1.2 “Spin” &amp; Narrative  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Treat proposal as a sales pitch → hook reader early.  </li>
<li style="margin-left: 0px;">Use engaging language; avoid dry listing of facts.  </li>
</ul>
</div></details>
</div></details>
<details><summary><strong>2. Selecting the Appropriate Grant Mechanism  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Match <strong>career stage</strong>, <strong>preliminary data</strong>, and <strong>project development level</strong> to mechanism.  </li>
</ul>
<details><summary><strong>2.1 Career‑Stage Considerations  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Early investigators: consider R03, R21, K99, or training awards (T/F series).  </li>
<li style="margin-left: 0px;">Senior investigators: eligible for R01, P series, center grants.  </li>
</ul>
</div></details>
<details><summary><strong>2.2 Project Development Stage  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;"><strong>Pilot data present</strong> → R01 possible.  </li>
<li style="margin-left: 0px;"><strong>Exploratory phase</strong> → R21 (≤ $275k total, ≤ $200k/yr, ≤ 2 yr).  </li>
<li style="margin-left: 0px;"><strong>Small, self‑contained study</strong> → R03 (≤ $50k/yr, ≤ 2 yr, no renewal).  </li>
</ul>
</div></details>
<details><summary><strong>2.3 Funding Purpose  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Research execution → R01/R21/R03.  </li>
<li style="margin-left: 0px;">Ongoing program structure → P30/P50/P60 center grants.  </li>
<li style="margin-left: 0px;">Commercialization → SBIR/STTR (R41/R42/R43/R44).  </li>
</ul>
</div></details>
</div></details>
<details><summary><strong>3. Core Grant Classes &amp; Key Features  </strong></summary><div style="padding-left: 20px;">
<table border="1" cellspacing="0" cellpadding="4">
<thead><tr>
<th>Class</th>
<th>Typical Awardee</th>
<th>Budget Limits</th>
<th>Project Period</th>
<th>Renewal?</th>
<th>Pilot Data Required</th>
</tr></thead>
<tbody>
<tr>
<td><strong>R01</strong> (Research Project)</td>
<td>Established investigators</td>
<td>$499,999/yr max</td>
<td>≤ 5 yr</td>
<td>Yes</td>
<td>Preferred</td>
</tr>
<tr>
<td><strong>R21</strong> (Exploratory/Developmental)</td>
<td>Early‑stage, high‑risk ideas</td>
<td>$275k total; $200k max/yr</td>
<td>≤ 2 yr</td>
<td>No</td>
<td>Not required (but helpful)</td>
</tr>
<tr>
<td><strong>R03</strong> (Small Grant)</td>
<td>Students, new investigators</td>
<td>$50k/yr max</td>
<td>≤ 2 yr</td>
<td>No</td>
<td>Not required</td>
</tr>
<tr>
<td><strong>K series</strong> (Career Development)</td>
<td>Post‑doc to early faculty</td>
<td>Varies by K award</td>
<td>3–5 yr</td>
<td>No</td>
<td>Yes (often requires mentor support)</td>
</tr>
<tr>
<td><strong>T/F series</strong> (Training &amp; Fellowships)</td>
<td>Predoctoral/postdoctoral trainees</td>
<td>Varies</td>
<td>1–3 yr</td>
<td>N/A</td>
<td>Not applicable</td>
</tr>
<tr>
<td><strong>P series</strong> (Program/Center)</td>
<td>Senior investigators, multiple sites</td>
<td>Institutional; up to millions</td>
<td>≥ 5 yr</td>
<td>No</td>
<td>Depends on sub‑project</td>
</tr>
<tr>
<td><strong>U series</strong> (Cooperative Agreements)</td>
<td>Projects needing agency staff involvement</td>
<td>Varies</td>
<td>Variable</td>
<td>Yes/No</td>
<td>Varies</td>
</tr>
<tr>
<td><strong>SBIR/STTR</strong> (Small Business)</td>
<td>US small businesses</td>
<td>Phase I ≤ $150k; Phase II ≤ $1M</td>
<td>6 mo–2 yr (Phase I); 2 yr (Phase II)</td>
<td>No (Phase III unfunded)</td>
<td>Pilot data often required for Phase II</td>
</tr>
</tbody>
</table>
<details><summary><strong>3.1 R03 – Small Grant Details  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;"><strong>Budget</strong>: ≤ $50k direct costs/yr; up to $100k total possible with indirects.  </li>
<li style="margin-left: 0px;"><strong>Scope</strong>: pilot/feasibility, secondary data analysis, methodology development.  </li>
<li style="margin-left: 0px;"><strong>No renewal</strong>, no mandatory preliminary data (optional).  </li>
</ul>
</div></details>
<details><summary><strong>3.2 R21 – Exploratory Grant Details  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;"><strong>Budget</strong>: ≤ $275k total; ≤ $200k in any single year.  </li>
<li style="margin-left: 0px;"><strong>Scope</strong>: high‑risk/high‑reward, novel concepts, distinct from R01 aims.  </li>
<li style="margin-left: 0px;"><strong>No renewal</strong>, pilot data optional but strongly encouraged by reviewers.  </li>
</ul>
</div></details>
<details><summary><strong>3.3 Career Development (K) Awards  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;"><strong>K99/R00</strong>: transition to independence; requires strong mentor plan &amp; publications.  </li>
<li style="margin-left: 0px;"><strong>K01/K08/K23</strong>: disease‑specific or methodology focus; salary + research support.  </li>
</ul>
</div></details>
</div></details>
<details><summary><strong>4. Practical Tips for Mechanism Selection  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;"><strong>Consult senior mentors</strong> and institute program officers early.  </li>
<li style="margin-left: 0px;">Verify <strong>institutional eligibility rules</strong> (e.g., some schools restrict K awards to certain years post‑degree).  </li>
<li style="margin-left: 0px;">Check <strong>Institute/Center (I/C) participation</strong>: not all I/Cs fund every mechanism (e.g., NHLBI may not support R21).  </li>
<li style="margin-left: 0px;">Use <strong>FOA numbers</strong> (parent announcements) to locate exact eligibility and budget caps.  </li>
</ul>
<details><summary><strong>4.1 FOA Navigation  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Locate on Grants.gov → “Parent Announcements” tab.  </li>
<li style="margin-left: 0px;">Identify <strong>FOA ID</strong>, submission dates, and I/C‑specific interest statements.  </li>
</ul>
</div></details>
<details><summary><strong>4.2 RePORT &amp; Success Rates  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Review NIH RePORTER for institute‑specific success rates (FY2015–2022).  </li>
<li style="margin-left: 0px;">Use rates as <em>informational</em>, not deterministic, guidance.  </li>
</ul>
<p><em>End of Part 1 – covering foundational concepts, mechanism selection criteria, and core grant classes.</em></p>
</div></details>
</div></details>
<details><summary><strong>5. Application Characteristics &amp; Submission Logistics  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;"><strong>Project period</strong>: up to 2 yr (R03/R21) or 5 yr (R01); specify start/end dates.  </li>
<li style="margin-left: 0px;"><strong>Budget caps</strong>: adhere strictly to FOA limits; indirect costs follow institutional rate.  </li>
<li style="margin-left: 0px;"><strong>Preliminary data</strong>: optional for R03/R21, required for most K and R01 submissions.  </li>
<li style="margin-left: 0px;"><strong>Research Strategy length</strong>: ≤ 6 pages (R03/R21); ≤ 12 pages (R01).  </li>
</ul>
<details><summary><strong>5.1 Required Sections (PHS 398)  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Cover Letter, Project Summary/Abstract, Specific Aims, Research Strategy, Biosketches, Facilities &amp; Resources, Budget Justification.  </li>
<li style="margin-left: 0px;"><strong>Appendices</strong>: only allowed if FOA permits; otherwise omitted.  </li>
</ul>
<details><summary><strong>5.1.1 Specific Aims (≤ 1 page)  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">State hypothesis, objectives, and expected outcomes concisely.  </li>
<li style="margin-left: 0px;">Include <strong>impact statement</strong> linking to public‑health relevance.  </li>
</ul>
</div></details>
<details><summary><strong>5.1.2 Research Strategy (≤ 6/12 pages)  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;"><strong>Significance</strong>: why problem matters; cite epidemiology or burden.  </li>
<li style="margin-left: 0px;"><strong>Innovation</strong>: novel concepts, methods, or technologies.  </li>
<li style="margin-left: 0px;"><strong>Approach</strong>: design, population, power calculations, statistical plan, potential pitfalls &amp; alternatives.  </li>
</ul>
</div></details>
</div></details>
<details><summary><strong>5.2 Submission Timing &amp; Technical Tips  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Upload to <strong>Grants.gov</strong> via NIH eRA Commons; allow ≥ 48 h for system checks.  </li>
<li style="margin-left: 0px;">Submit <strong>2–3 days before deadline</strong> to troubleshoot upload errors.  </li>
<li style="margin-left: 0px;">Verify <strong>FOA number</strong>, PI eligibility, and institutional approvals prior to submission.  </li>
</ul>
<details><summary><strong>5.2.1 Common Technical Pitfalls  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">File size &gt; 10 MB → split PDFs or compress images.  </li>
<li style="margin-left: 0px;">Missing <strong>human subjects</strong> or <strong>animal use</strong> certifications → application rejected.  </li>
<li style="margin-left: 0px;">Inconsistent <strong>budget totals</strong> between forms → system error flag.  </li>
</ul>
</div></details>
</div></details>
</div></details>
<details><summary><strong>6. Research Supplements &amp; Diversity Programs  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Supplements add funds to an existing grant to support under‑represented investigators or specific project extensions.  </li>
</ul>
<details><summary><strong>6.1 Eligibility &amp; Funding Sources  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">PI must have ≥ 2 yr remaining on a parent award (R01, R21, P series, etc.).  </li>
<li style="margin-left: 0px;">Eligible candidates: <strong>racial/ethnic minorities</strong>, individuals with disabilities, economically disadvantaged, or those with career interruptions (2–8 yr).  </li>
</ul>
<details><summary><strong>6.1.1 Grant Types Accepting Supplements  </strong></summary><div style="padding-left: 20px;">
<table border="1" cellspacing="0" cellpadding="4">
<thead><tr>
<th>Parent Award</th>
<th>Example Mechanisms</th>
</tr></thead>
<tbody>
<tr>
<td>Research Project</td>
<td>R01, R21, R03, R00</td>
</tr>
<tr>
<td>Multi‑Project</td>
<td>P30, P50, P60</td>
</tr>
<tr>
<td>Small Business</td>
<td>R41, R42, R43, R44</td>
</tr>
<tr>
<td>Cooperative Agreements</td>
<td>U01, U10, U19</td>
</tr>
<tr>
<td>Director’s Awards</td>
<td>DP1, DP2</td>
</tr>
</tbody>
</table>
</div></details>
</div></details>
<details><summary><strong>6.2 Application Components  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;"><strong>Supplemental Budget</strong>: ≤ parent award amount; justify salary, fringe, and research costs.  </li>
<li style="margin-left: 0px;"><strong>Candidate Statement</strong>: describe training plan, mentorship, and career development goals.  </li>
<li style="margin-left: 0px;"><strong>Integration Plan</strong>: how the supplement activity fits within the parent project’s aims.  </li>
</ul>
<details><summary><strong>6.2.1 Review Criteria for Supplements  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Candidate’s potential to become an independent researcher.  </li>
<li style="margin-left: 0px;">Quality of mentorship &amp; institutional support.  </li>
<li style="margin-left: 0px;">Scientific merit of proposed supplemental work.  </li>
</ul>
</div></details>
</div></details>
<details><summary><strong>6.3 Administrative vs. Research Supplements  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;"><strong>Administrative</strong>: used for salary or fringe when PI has &lt; 2 yr left on parent award; limited to ≤ $100k total.  </li>
<li style="margin-left: 0px;"><strong>Research</strong>: adds new scientific aims; may include equipment, consumables, and travel.  </li>
</ul>
</div></details>
</div></details>
<details><summary><strong>7. Success Rates, Funding Landscape &amp; Strategic Planning  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Success rates differ by Institute/Center (I/C) and mechanism; they are percentages of reviewed applications that receive funding.  </li>
</ul>
<details><summary><strong>7.1 How NIH Calculates Success Rates  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;"><strong>Formula</strong>: (Funded competing + funded carryovers) ÷ (Competing applications + carryovers).  </li>
<li style="margin-left: 0px;">Excludes withdrawn, administratively returned, or non‑reviewed submissions.  </li>
</ul>
<details><summary><strong>7.1.1 Example FY2015 Data (selected I/Cs)  </strong></summary><div style="padding-left: 20px;">
<table border="1" cellspacing="0" cellpadding="4">
<thead><tr>
<th>Mechanism</th>
<th>NCI</th>
<th>NHLBI</th>
<th>NINDS</th>
<th>NIMH</th>
</tr></thead>
<tbody>
<tr>
<td>R01</td>
<td>13.8 %</td>
<td>22.5 %</td>
<td>20.2 %</td>
<td>23.3 %</td>
</tr>
<tr>
<td>R03</td>
<td>9.9 %</td>
<td>60.0 % (small sample)</td>
<td>12.3 %</td>
<td>24.8 %</td>
</tr>
<tr>
<td>R21</td>
<td>8.7 %</td>
<td>17.6 %</td>
<td>18.9 %</td>
<td>19.7 %</td>
</tr>
<tr>
<td>K99</td>
<td>32.1 %</td>
<td>25.8 %</td>
<td>9.2 %</td>
<td>23.3 %</td>
</tr>
</tbody>
</table>
</div></details>
</div></details>
<details><summary><strong>7.2 Interpreting Success Rates  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">High rates (e.g., NHLBI R03) may reflect <strong>limited submissions</strong>; low rates indicate <strong>high competition</strong>.  </li>
<li style="margin-left: 0px;">Use rates as <em>context</em>, not deterministic guidance; align proposal quality with institute priorities.  </li>
</ul>
<details><summary><strong>7.2.1 Strategic Recommendations  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Target <strong>multiple I/Cs</strong> when possible to broaden funding pool.  </li>
<li style="margin-left: 0px;">Align <strong>research theme</strong> with current NIH strategic plans (e.g., precision medicine, AI in health).  </li>
<li style="margin-left: 0px;">Leverage <strong>pilot data</strong> from smaller mechanisms (R03) to strengthen later R01 submissions.  </li>
</ul>
</div></details>
</div></details>
<details><summary><strong>7.3 Monitoring Funding Opportunities  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Regularly check <strong>NIH Guide for Grants and Contracts</strong>, <strong>RePORTER</strong>, and institute‑specific newsletters.  </li>
<li style="margin-left: 0px;">Set alerts for <strong>FOA releases</strong> relevant to your research area.  </li>
</ul>
</div></details>
</div></details>
<details><summary><strong>8. Small Business Innovation Research (SBIR) &amp; Small Business Technology Transfer (STTR) Programs  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Designed for U.S. small businesses to develop health‑related technologies with commercial potential.  </li>
</ul>
<details><summary><strong>8.1 Program Structure &amp; Phases  </strong></summary><div style="padding-left: 20px;">
<table border="1" cellspacing="0" cellpadding="4">
<thead><tr>
<th>Phase</th>
<th>SBIR</th>
<th>STTR</th>
</tr></thead>
<tbody>
<tr>
<td>I</td>
<td>≤ $150k total, 6 mo (SBIR) or 12 mo (STTR)</td>
<td>Same limits; PI must be ≥ 51 % employed by business.</td>
</tr>
<tr>
<td>II</td>
<td>≤ $1M total, 2 yr</td>
<td>Same limits; small business performs ≥ 40 % of work, partner ≥ 30 %.</td>
</tr>
<tr>
<td>III</td>
<td>No NIH funding (commercialization)</td>
<td>Same as SBIR – no direct NIH support.</td>
</tr>
</tbody>
</table>
<details><summary><strong>8.1.1 Fast‑Track Applications  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Submit combined Phase I &amp; II at a single deadline.  </li>
<li style="margin-left: 0px;">Advantages: seamless transition, reduced gap between phases.  </li>
<li style="margin-left: 0px;">Risks: higher workload; only ~20 % funded.  </li>
</ul>
</div></details>
</div></details>
<details><summary><strong>8.2 Eligibility &amp; PI Employment Rules  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;"><strong>SBIR</strong>: PI must be primarily employed (&gt; 51 %) by the small business for award duration (waiver possible).  </li>
<li style="margin-left: 0px;"><strong>STTR</strong>: No primary‑employment requirement; PI may reside at collaborating nonprofit research institution.  </li>
</ul>
<details><summary><strong>8.2.1 Research Partner Requirements  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;"><strong>SBIR</strong>: Allows subcontractors up to 33 % (Phase I) or 50 % (Phase II) of total costs.  </li>
<li style="margin-left: 0px;"><strong>STTR</strong>: Requires formal collaboration with a nonprofit; small business must perform ≥ 40 %, partner ≥ 30 %.  </li>
</ul>
</div></details>
</div></details>
<details><summary><strong>8.3 Budget &amp; Cost Allocation Rules  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Direct costs limited as above; indirect costs follow institutional negotiated rate.  </li>
<li style="margin-left: 0px;">Phase I: ≤ 33 % of total may be paid to external parties (SBIR) or partners (STTR).  </li>
<li style="margin-left: 0px;">Phase II: ≤ 50 % external for SBIR; STTR maintains ≥ 40 % internal work.  </li>
</ul>
<details><summary><strong>8.3.1 Example Cost Distribution (Phase II, SBIR)  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Total award: $800k  </li>
<li style="margin-left: 0px;">Small business direct costs: $480k (60 %)  </li>
<li style="margin-left: 0px;">Subcontracted research institution: $240k (30 %)  </li>
<li style="margin-left: 0px;">Other consultants/consortium: $80k (10 %)  </li>
</ul>
</div></details>
</div></details>
<details><summary><strong>8.4 Commercialization Considerations  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Phase III not NIH‑funded; requires private investment, venture capital, or licensing.  </li>
<li style="margin-left: 0px;">Early planning for <strong>intellectual property</strong>, <strong>regulatory pathway</strong>, and <strong>market analysis</strong> is essential.  </li>
</ul>
<details><summary><strong>8.4.1 Institutional Implications for PI  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Employment at small business may affect <strong>benefits</strong>, <strong>salary support</strong>, and <strong>institutional affiliation</strong>.  </li>
<li style="margin-left: 0px;">Negotiate <strong>effort allocation</strong> to satisfy both employer and NIH requirements.  </li>
</ul>
</div></details>
</div></details>
<details><summary><strong>8.5 Areas of NIH Interest for SBIR/STTR  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Any biomedical or behavioral research aligning with NIH mission (e.g., digital health, diagnostics, therapeutics).  </li>
<li style="margin-left: 0px;">Review institute‑specific solicitations for priority topics (e.g., cancer imaging, neurotechnology).  </li>
</ul>
<p><em>End of Part 2 – covering application logistics, supplements, success‑rate context, and SBIR/STTR program details.</em></p>
</div></details>
</div></details>
<details><summary><strong>9. Interacting with NIH Program Officers &amp; Institute Contacts  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Early communication improves alignment of proposal with institute priorities.  </li>
</ul>
<details><summary><strong>9.1 When to Contact  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;"><strong>Pre‑submission</strong>: after idea formulation, before FOA selection.  </li>
<li style="margin-left: 0px;"><strong>During concept development</strong>: to verify mechanism suitability and eligibility.  </li>
<li style="margin-left: 0px;"><strong>After receipt notice</strong>: for clarification on reviewer comments (if resubmitting).  </li>
</ul>
<details><summary><strong>9.1.1 Preferred Communication Channels  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Email (use institutional email address).  </li>
<li style="margin-left: 0px;">Phone call (schedule brief 15‑min slot).  </li>
<li style="margin-left: 0px;">Attend institute webinars or “grant writing clinics”.  </li>
</ul>
</div></details>
</div></details>
<details><summary><strong>9.2 Information to Provide PO  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Brief project summary (≤ 250 words).  </li>
<li style="margin-left: 0px;">Proposed mechanism and budget range.  </li>
<li style="margin-left: 0px;">PI’s career stage and prior funding record.  </li>
<li style="margin-left: 0px;">Specific questions (e.g., eligibility, FOA relevance, special requirements).  </li>
</ul>
<details><summary><strong>9.2.1 Expected PO Responses  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Confirmation of <strong>mechanism fit</strong>.  </li>
<li style="margin-left: 0px;">Guidance on <strong>FOA nuances</strong> (e.g., special review criteria).  </li>
<li style="margin-left: 0px;">Referral to <strong>relevant program staff</strong> or <strong>institutional contacts</strong>.  </li>
</ul>
</div></details>
</div></details>
<details><summary><strong>9.3 Documentation of Interaction  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Save email threads; reference PO name and date in the <strong>Cover Letter</strong> if appropriate.  </li>
</ul>
</div></details>
</div></details>
<details><summary><strong>10. Peer Review Process &amp; Scoring Criteria  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Applications undergo <strong>Scientific Review Group (SRG)</strong> evaluation followed by <strong>Institute/Center (IC) Council</strong> review.  </li>
</ul>
<details><summary><strong>10.1 Review Stages  </strong></summary><div style="padding-left: 20px;">
<p>1. <strong>Initial Peer Review</strong> – reviewers assign overall impact score (1 = best, 9 = worst).</p>
<p>2. <strong>Second‑Level Review</strong> – IC leadership considers relevance to institute mission and budget constraints.</p>
<details><summary><strong>10.1.1 Scoring Components (R01/R21/R03)  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;"><strong>Significance</strong> (0–3 points) – importance of problem addressed.  </li>
<li style="margin-left: 0px;"><strong>Investigator(s)</strong> (0–2) – qualifications, track record.  </li>
<li style="margin-left: 0px;"><strong>Innovation</strong> (0–2) – novelty of approach.  </li>
<li style="margin-left: 0px;"><strong>Approach</strong> (0–12) – design, methods, feasibility, statistical plan.  </li>
<li style="margin-left: 0px;"><strong>Environment</strong> (0–2) – institutional resources, collaborations.  </li>
</ul>
</div></details>
</div></details>
<details><summary><strong>10.2 Reviewer Types  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;"><strong>Primary reviewers</strong> (assign overall impact).  </li>
<li style="margin-left: 0px;"><strong>Secondary reviewers</strong> (provide additional comments).  </li>
<li style="margin-left: 0px;"><strong>Discussants</strong> (lead group discussion).  </li>
</ul>
<details><summary><strong>10.2.1 Conflict‑of‑Interest Management  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Reviewers must disclose any personal, professional, or financial conflicts; NIH excludes conflicted reviewers from scoring.  </li>
</ul>
</div></details>
</div></details>
<details><summary><strong>10.3 Common Reviewer Critiques &amp; Mitigation Strategies  </strong></summary><div style="padding-left: 20px;">
<table border="1" cellspacing="0" cellpadding="4">
<thead><tr>
<th>Issue</th>
<th>Typical Comment</th>
<th>Mitigation</th>
</tr></thead>
<tbody>
<tr>
<td>Lack of preliminary data</td>
<td>“Insufficient pilot work to support feasibility.”</td>
<td>Include <strong>pilot data</strong> if available; add <strong>power calculations</strong> and <strong>contingency plans</strong>.</td>
</tr>
<tr>
<td>Over‑ambitious scope</td>
<td>“Aims are too broad for the budget period.”</td>
<td>Refine aims to be <strong>specific, measurable</strong>, and aligned with budget.</td>
</tr>
<tr>
<td>Weak statistical plan</td>
<td>“Statistical methods not fully described.”</td>
<td>Provide detailed <strong>analysis plan</strong>, assumptions, and justification of sample size.</td>
</tr>
<tr>
<td>Inadequate environment</td>
<td>“Institution lacks required core facilities.”</td>
<td>Secure <strong>letters of support</strong> from collaborating cores; describe access agreements.</td>
</tr>
</tbody>
</table>
</div></details>
</div></details>
<details><summary><strong>11. Budget Construction &amp; Justification  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Follow <strong>NIH Cost Principles</strong> (2 CFR Part 200) and institute‑specific caps.  </li>
</ul>
<details><summary><strong>11.1 Direct Costs Categories  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;"><strong>Personnel</strong>: salaries, fringe benefits, effort percentages.  </li>
<li style="margin-left: 0px;"><strong>Equipment</strong>: only if essential; must be justified and within cap.  </li>
<li style="margin-left: 0px;"><strong>Supplies</strong>: consumables, reagents, software licenses.  </li>
<li style="margin-left: 0px;"><strong>Travel</strong>: conferences, collaborator visits (≤ 5 % of total direct costs).  </li>
<li style="margin-left: 0px;"><strong>Participant Costs</strong>: recruitment, incentives, clinical procedures.  </li>
</ul>
<details><summary><strong>11.1.1 Personnel Effort Calculation Example (R01)  </strong></summary><div style="padding-left: 20px;">
<table border="1" cellspacing="0" cellpadding="4">
<thead><tr>
<th>Role</th>
<th>Annual Salary</th>
<th>% Effort</th>
<th>Fringe (30 %)</th>
<th>Total Direct Cost</th>
</tr></thead>
<tbody>
<tr>
<td>PI</td>
<td>$150,000</td>
<td>10 %</td>
<td>$4,500</td>
<td>$19,500</td>
</tr>
<tr>
<td>Co‑I</td>
<td>$120,000</td>
<td>5 %</td>
<td>$3,600</td>
<td>$9,600</td>
</tr>
<tr>
<td>Postdoc</td>
<td>$55,000</td>
<td>50 %</td>
<td>$1,650</td>
<td>$28,250</td>
</tr>
</tbody>
</table>
</div></details>
</div></details>
<details><summary><strong>11.2 Indirect Costs (Facilities &amp; Administrative)  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Apply institutional negotiated rate (e.g., <strong>52 %</strong> of Modified Total Direct Costs).  </li>
</ul>
<details><summary><strong>11.2.1 Calculation Example  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;"><strong>Modified Total Direct Costs (MTDC)</strong> = Direct costs – equipment &gt; $25k, tuition, patient care fees.  </li>
<li style="margin-left: 0px;">MTDC = $300,000 → Indirect = $156,000 (52 %).  </li>
<li style="margin-left: 0px;"><strong>Total Award</strong> = $456,000.  </li>
</ul>
</div></details>
</div></details>
<details><summary><strong>11.3 Budget Justification Narrative  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Explain each line item’s relevance to aims.  </li>
<li style="margin-left: 0px;">Cite <strong>institutional support letters</strong> for core facilities.  </li>
<li style="margin-left: 0px;">Provide <strong>cost‑sharing</strong> details if applicable.  </li>
</ul>
<details><summary><strong>11.3.1 Sample Justification Snippet  </strong></summary><div style="padding-left: 20px;">
<p>&gt; <em>Personnel</em>: PI effort (10 %) supports overall project coordination and data analysis; Co‑I provides expertise in imaging acquisition (5 %). Postdoctoral fellow (50 % effort) conducts daily experiments, data processing, and manuscript drafting. <em>Supplies</em>: reagents for ELISA kits ($12k), sequencing library prep ($8k). <em>Travel</em>: $3k allocated for presentation at the annual Society of Neuroscience meeting to disseminate findings.</p>
</div></details>
</div></details>
</div></details>
<details><summary><strong>12. Post‑Submission Activities &amp; Resubmission Strategies  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">After <strong>Notice of Award (NoA)</strong> or <strong>Summary Statement</strong>, plan next steps.  </li>
</ul>
<details><summary><strong>12.1 If Funded  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Review NoA for <strong>award terms</strong>, <strong>budget adjustments</strong>, and <strong>reporting requirements</strong>.  </li>
<li style="margin-left: 0px;">Set up <strong>grant management system</strong> (e.g., eRA Commons, institutional grants office).  </li>
</ul>
<details><summary><strong>12.1.1 Required Reporting  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;"><strong>Annual Progress Report (PHS 398)</strong> – scientific updates, budget expenditures.  </li>
<li style="margin-left: 0px;"><strong>Final Report</strong> – outcomes, publications, data sharing compliance.  </li>
</ul>
</div></details>
</div></details>
<details><summary><strong>12.2 If Not Funded – Analyzing the Summary Statement  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Identify <strong>major score components</strong> (e.g., Approach = 3, Significance = 1).  </li>
<li style="margin-left: 0px;">Note reviewer comments marked <strong>“Major”</strong>, <strong>“Minor”</strong>, or <strong>“Unaddressed”.</strong>  </li>
</ul>
<details><summary><strong>12.2.1 Resubmission Timeline  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Minimum <strong>30‑day</strong> interval before resubmitting to same FOA (unless new FOA issued).  </li>
<li style="margin-left: 0px;">Revise <strong>Specific Aims</strong> and <strong>Research Strategy</strong> based on critiques.  </li>
</ul>
</div></details>
</div></details>
<details><summary><strong>12.3 Common Resubmission Enhancements  </strong></summary><div style="padding-left: 20px;">
<table border="1" cellspacing="0" cellpadding="4">
<thead><tr>
<th>Issue</th>
<th>Revision Action</th>
</tr></thead>
<tbody>
<tr>
<td>Weak preliminary data</td>
<td>Add <strong>new pilot results</strong>, or cite external datasets.</td>
</tr>
<tr>
<td>Inadequate statistical plan</td>
<td>Incorporate <strong>biostatistician review</strong>, provide power analysis tables.</td>
</tr>
<tr>
<td>Insufficient innovation</td>
<td>Emphasize <strong>novel technology</strong> or <strong>unique cohort</strong>; add comparative literature.</td>
</tr>
<tr>
<td>Budget concerns</td>
<td>Re‑budget to align with <strong>FOA caps</strong>, justify each cost more explicitly.</td>
</tr>
</tbody>
</table>
</div></details>
<details><summary><strong>12.4 Resubmission Submission Checklist  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Updated <strong>Specific Aims</strong> (≤ 1 page).  </li>
<li style="margin-left: 0px;">Revised <strong>Research Strategy</strong> addressing all reviewer points.  </li>
<li style="margin-left: 0px;">New <strong>Biosketches</strong> reflecting recent publications.  </li>
<li style="margin-left: 0px;">Adjusted <strong>Budget &amp; Justification</strong>.  </li>
<li style="margin-left: 0px;"><strong>Cover Letter</strong> stating “Resubmission – Application ID: XXXXXX, FOA: YYYYY”.  </li>
</ul>
</div></details>
</div></details>
<details><summary><strong>13. Ethical Considerations &amp; Compliance Requirements  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Ensure adherence to NIH policies on <strong>human subjects</strong>, <strong>animal welfare</strong>, <strong>data sharing</strong>, and <strong>conflict of interest</strong>.  </li>
</ul>
<details><summary><strong>13.1 Human Subjects Protection (45 CFR 46)  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Submit <strong>IRB approval letter</strong> or <strong>exemption determination</strong> with application.  </li>
<li style="margin-left: 0px;">Include <strong>Inclusion‑Enrollment Report</strong> for women, minorities, children.  </li>
</ul>
<details><summary><strong>13.1.1 Key Elements in Human Subjects Section  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Risk assessment and mitigation strategies.  </li>
<li style="margin-left: 0px;">Informed consent process description.  </li>
<li style="margin-left: 0px;">Data safety monitoring plan (if applicable).  </li>
</ul>
</div></details>
</div></details>
<details><summary><strong>13.2 Animal Welfare (PHS Policy)  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Provide <strong>IACUC approval</strong> documentation.  </li>
<li style="margin-left: 0px;">Detail <strong>species</strong>, <strong>number of animals</strong>, <strong>justification</strong>, and <strong>euthanasia methods</strong>.  </li>
</ul>
</div></details>
<details><summary><strong>13.3 Data Sharing &amp; Transparency  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">NIH Data Management Plan required for &gt; $500k direct costs.  </li>
<li style="margin-left: 0px;">Specify repository (e.g., dbGaP, Dryad) and timeline for data release.  </li>
</ul>
<details><summary><strong>13.3.1 Example Data‑Sharing Statement  </strong></summary><div style="padding-left: 20px;">
<p>&gt; <em>All de‑identified genomic datasets will be deposited in the NIH‐supported dbGaP repository within 12 months of publication; code for analysis pipelines will be posted on GitHub with appropriate licensing.</em></p>
</div></details>
</div></details>
<details><summary><strong>13.4 Conflict‑of‑Interest Disclosure  </strong></summary><div style="padding-left: 20px;">
<ul style="list-style-type: disc;">
<li style="margin-left: 0px;">Complete <strong>eRA Commons COI</strong> module for all key personnel.  </li>
<li style="margin-left: 0px;">Disclose <strong>financial interests</strong>, <strong>consulting fees</strong>, and <strong>equity holdings</strong> related to the research area.  </li>
</ul>
<p><em>End of Part 3 – covering program officer interaction, peer review, budgeting, post‑submission actions, and compliance.</em></p>
</div></details>
</div></details>
</div></details>
</div>
</div>

<br>
<br>
<br>
<br>
<br>


<script>
// --- State Management for Expansion Level ---
let currentLevel = 1; 
const maxLevel = 10;
const minLevel = 1;

// --- Core Function to Set Mindmap Expansion ---
function setMindmapLevel(level) {
    const allDetails = document.querySelectorAll('.mindmap details');
    allDetails.forEach(detail => detail.removeAttribute('open'));
    allDetails.forEach(detail => {
        let depth = 0;
        let parent = detail.parentElement;
        while (parent && parent.tagName !== 'BODY') {
            if (parent.tagName === 'DETAILS') {
                depth++;
            }
            parent = parent.parentElement;
        }
        if (depth < level) {
            detail.setAttribute('open', '');
        }
    });
}

// --- Control Functions ---
function zoomIn() {
    if (currentLevel < maxLevel) {
        currentLevel++;
        setMindmapLevel(currentLevel);
    }
}

function zoomOut() {
    if (currentLevel > minLevel) {
        currentLevel--;
        setMindmapLevel(currentLevel);
    }
}

function resetView() {
    currentLevel = minLevel;
    setMindmapLevel(currentLevel);
}


// --- NEW: Function to Toggle Read/Quiz Mode ---
function toggleReadMode() {
    const mindmapContainer = document.querySelector('.mindmap');
    if (mindmapContainer) {
        mindmapContainer.classList.toggle('read-mode');
    }
}

// --- Draggable Controls ---
function dragElement(elmnt) {
    let pos1 = 0, pos2 = 0, pos3 = 0, pos4 = 0;
    const onMouseDown = (e) => {
        e = e || window.event;
        e.preventDefault();
        pos3 = e.clientX;
        pos4 = e.clientY;
        document.onmouseup = closeDragElement;
        document.onmousemove = elementDrag;
    };
    const elementDrag = (e) => {
        e = e || window.event;
        e.preventDefault();
        pos1 = pos3 - e.clientX;
        pos2 = pos4 - e.clientY;
        pos3 = e.clientX;
        pos4 = e.clientY;
        elmnt.style.top = (elmnt.offsetTop - pos2) + "px";
        elmnt.style.left = (elmnt.offsetLeft - pos1) + "px";
        elmnt.style.transform = "none";
        elmnt.style.bottom = "auto";
    };
    const closeDragElement = () => {
        document.onmouseup = null;
        document.onmousemove = null;
    };
    if (document.getElementById(elmnt.id)) {
        document.getElementById(elmnt.id).onmousedown = onMouseDown;
    } else {
        elmnt.onmousedown = onMouseDown;
    }
}




// --- Initial Setup ---
window.addEventListener('DOMContentLoaded', () => {
    // Set the initial mindmap view
    setMindmapLevel(currentLevel);

    // Get the draggable controls element
    const controls = document.getElementById('level-controls');
    if (controls) {
        dragElement(controls);
    }

    // --- CORRECTED & IMPROVED: Setup for Click-to-Reveal ---
    const mindmapContainer = document.querySelector('.mindmap');
    if (mindmapContainer) {
        mindmapContainer.addEventListener('click', function(event) {
            // Use .closest() to find the nearest parent <q> tag.
            // This is more robust than checking event.target.tagName.
            const quoteElement = event.target.closest('q');
            
            if (quoteElement) {
                // Add the 'is-revealed' class to show the text
                quoteElement.classList.add('is-revealed');
            }
        });
    }
});
</script>

</body>
</html>
